home / stock / cnbx / cnbx quote
Last: | $0.011 |
---|---|
Change Percent: | 1.85% |
Open: | $0.0103 |
Close: | $0.0108 |
High: | $0.0112 |
Low: | $0.0102 |
Volume: | 547,794 |
Last Trade Date Time: | 04/29/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.011 | $0.0103 | $0.0108 | $0.0112 | $0.0102 | 547,794 | 04-29-2024 |
$0.0108 | $0.01222 | $0.0108 | $0.01245 | $0.0107 | 1,210,157 | 04-26-2024 |
$0.013 | $0.01264 | $0.013 | $0.0133 | $0.0113 | 122,120 | 04-25-2024 |
$0.011975 | $0.011975 | $0.011975 | $0.011975 | $0.011975 | 28,755 | 04-24-2024 |
$0.01235 | $0.012 | $0.01235 | $0.01268 | $0.012 | 20,216 | 04-23-2024 |
$0.011975 | $0.0125 | $0.011975 | $0.0125 | $0.0112 | 73,173 | 04-22-2024 |
$0.0114 | $0.0115 | $0.0114 | $0.0136 | $0.0104 | 263,052 | 04-19-2024 |
$0.0104 | $0.0104 | $0.0104 | $0.0104 | $0.0104 | 127 | 04-18-2024 |
$0.01225 | $0.011 | $0.01225 | $0.0146 | $0.01 | 284,118 | 04-17-2024 |
$0.01245 | $0.0117 | $0.01245 | $0.01284 | $0.0116 | 60,406 | 04-16-2024 |
$0.0117 | $0.01269 | $0.0117 | $0.01354 | $0.0115 | 81,642 | 04-15-2024 |
$0.0149 | $0.01316 | $0.0149 | $0.0149 | $0.0114 | 61,464 | 04-12-2024 |
$0.012 | $0.01406 | $0.012 | $0.01406 | $0.012 | 40,017 | 04-11-2024 |
$0.0135 | $0.0113 | $0.0135 | $0.0135 | $0.0113 | 17,605 | 04-10-2024 |
$0.0113 | $0.015 | $0.0113 | $0.015 | $0.0112 | 480,438 | 04-09-2024 |
$0.0132 | $0.0116 | $0.0132 | $0.0141 | $0.01 | 1,127,719 | 04-08-2024 |
$0.011 | $0.0131 | $0.011 | $0.0132 | $0.011 | 303,281 | 04-05-2024 |
$0.011 | $0.0159 | $0.011 | $0.0159 | $0.011 | 596,975 | 04-04-2024 |
$0.0148 | $0.013045 | $0.0148 | $0.0155 | $0.013045 | 46,597 | 04-03-2024 |
$0.01395 | $0.01476 | $0.01395 | $0.0159 | $0.012 | 45,000 | 04-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
Cannabics Pharmaceuticals Inc Company Name:
CNBX Stock Symbol:
OTCMKTS Market:
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma PR Newswire REHOVOT, Israel and BETHESDA, MD , Nov. 8, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader i...
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy PR Newswire REHOVOT, Israel and BETHESDA, MD. , Oct. 18, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of...
CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel PR Newswire REHOVOT, Israel and BETHESDA, Md. , Oct. 13, 2022 /PRNewswire/ - CNBX Pharmaceuticals Inc. (OTC-QB: CNBX),...